By Sheri Kasprzak
New York, Nov. 2 - HemoSense, Inc. said it will pocket $10 million from a private placement of units.
The company intends to sell 1,481,481 units at $6.75 each to a group of institutional investors by Nov. 4.
The units are comprised of one share and one half-share warrant. The whole warrants are exercisable at $8.165 each.
Based in San Jose, Calif., HemoSense develops technologies used to monitor blood coagulation to stop potential clots.
| Issuer: | HemoSense, Inc.
|
| Issue: | Units of one share and one half-share warrant
|
| Amount: | $10 million
|
| Shares: | 1,481,481
|
| Price: | $6.75
|
| Warrants: | One half-share warrant per share purchased
|
| Warrant strike price: | $8.165
|
| Announcement date: | Nov. 2
|
| Settlement date: | Nov. 4
|
| Stock price: | $7.00 at close Nov. 1
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
